Synapse - Mithat Gonen

Results (1032)

Functional assessment of the engraftment potential of gammaretrovirus- modified CD34 + cells, using a short serum-free transduction protocol

Journal Article

Budak-Alpdogan, T.; Przybylowski, M.; Gonen, M.; Sadelain, M.; Bertino, J.; Riviere, I.
Human Gene Therapy (2006)

Fulltext@MSK | Save

A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer

Journal Article

Brenner, B.; Shah, M. A.; Karpeh, M. S.; Gonen, M.; Brennan, M. F.; Coit, D. G.; Klimstra, D. S.; Tang, L. H.; Kelsen, D. P.
Annals of Oncology (2006)

Fulltext@MSK | Save

Utility of preoperative [(18)]F Fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients

Journal Article

Brady, M. S.; Akhurst, T.; Spanknebel, K.; Hilton, S.; Gonen, M.; Patel, A.; Larson, S.
Annals of Surgical Oncology (2006)

Fulltext@MSK | Save

Differential diagnosis of proximal biliary obstruction

Journal Article

Are, C.; Gonen, M.; D'Angelica, M.; DeMatteo, R. P.; Fong, Y.; Blumgart, L. H.; Jarnagin, W. R.
Surgery (2006)

Fulltext@MSK | Save

A selective approach to the resection of cystic lesions of the pancreas: Results from 539 consecutive patients

Journal Article

Allen, P. J.; D'Angelica, M.; Gonen, M.; Jaques, D. P.; Coit, D. G.; Jarnagin, W. R.; DeMatteo, R.; Fong, Y.; Blumgart, L. H.; Brennan, M. F.
Annals of Surgery (2006)

Fulltext@MSK | Save

Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatinirinotecan and radiotherapy

Meeting Abstract

Tew, W. P.; Minsky, B.; Bains, M.; Rizk, N.; Rusch, V.; Kelsen, D. P.; Shah, M.; Kepler, S.; Gonen, M.; Ilson, D. H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Predicting non-sentinel node status after positive sentinel lymph node biopsy for breast cancer: Clinicians versus nomogram

Meeting Abstract

Specht, M.; Kattan, M. W.; Gonen, M.; Fey, J.; Van Zee, K. J.
Annals of Surgical Oncology (2005)

Fulltext@MSK | Save

Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer

Meeting Abstract

Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

FDG-PET scanning impacts management in selected patients with high-risk breast carcinoma

Meeting Abstract

Port, E. R.; Yeung, H.; Gonen, M.; Caravelli, J.; Liberman, L.; Borgen, P. I.; Larson, S.
Annals of Surgical Oncology (2005)

Fulltext@MSK | Save

Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy

Meeting Abstract

Paoluzzi, L.; Gonen, M.; Toner, L.; Smith, E.; Yang, D.; Holmund, J.; Sorensen, M.; O'connor, O.
Blood (2005)

Fulltext@MSK | Save